PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2012

Jun 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2012-06-26

Reporting Person: BRYCE RICHARD PAUL (SR VP, CLINICAL RESEARCH & DEV)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-26	STOCK OPTION (RIGHT TO BUY)	$11.30	A	105000	Acquired	2022-06-26	COMMON STOCK (105000)	Direct

Footnotes

F1: The vesting commencement date ("Vesting Commencement Date") of the option is June 20, 2012. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to Reporting Person's continued services with the Issuer.